Phase I study of intravenous PSC-833 and doxorubicin: reversal of multidrug resistance.
Minami H, Ohtsu T, Fujii H, Igarashi T, Itoh K, Uchiyama-Kokubu N, Aizawa T, Watanabe T, Uda Y, Tanigawara Y, Sasaki Y.
Minami H, et al. Among authors: watanabe t.
Jpn J Cancer Res. 2001 Feb;92(2):220-30. doi: 10.1111/j.1349-7006.2001.tb01085.x.
Jpn J Cancer Res. 2001.
PMID: 11223552
Free PMC article.
Clinical Trial.